U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C15H9FN2.BrH
Molecular Weight 317.156
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of MFZ10-7 hydrobromide

SMILES

Br.CC1=NC(=CC=C1)C#CC2=CC(=CC(F)=C2)C#N

InChI

InChIKey=OEELBDJXBNRCRD-UHFFFAOYSA-N
InChI=1S/C15H9FN2.BrH/c1-11-3-2-4-15(18-11)6-5-12-7-13(10-17)9-14(16)8-12;/h2-4,7-9H,1H3;1H

HIDE SMILES / InChI

Molecular Formula BrH
Molecular Weight 80.912
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C15H9FN2
Molecular Weight 236.2438
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

MFZ 10-7 is a high affinity negative allosteric modulator at the mGlu5 receptor (Ki = 0.67 nM). MFZ 10-7 demonstrates anxyolitic properties in mouse models. Intraperitoneal administration of MFZ 10-7 inhibited intravenous cocaine self-administration, cocaine-induced reinstatement of drug-seeking behavior and cocaine-associated cue-induced cocaine-seeking behavior in rats.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: P41594
Gene ID: 2915.0
Gene Symbol: GRM5
Target Organism: Homo sapiens (Human)
1.22 nM [IC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Potent mGluR5 antagonists: pyridyl and thiazolyl-ethynyl-3,5-disubstituted-phenyl series.
2011 Jun 1
Metabotropic glutamate receptor 5 negative allosteric modulators as novel tools for in vivo investigation.
2012 Jul 12
A novel mGluR5 antagonist, MFZ 10-7, inhibits cocaine-taking and cocaine-seeking behavior in rats.
2014 Mar
Patents

Sample Use Guides

For anxyolitic tests MFZ 10-7 was delivered via ip injection 15 min prior to testing. Anxyolitic effects were observed at dose 0.3 mg/kg.
Route of Administration: Intraperitoneal
MFZ 10-7 was evaluated for antagonism of glutamate-mediated mobilization of internal calcium in an mGluR5 in vitro assay. MFZ 10-7 (compound 2d) inhibited mGluR5 with IC50 1.22 nM.
Substance Class Chemical
Created
by admin
on Sat Dec 16 19:19:53 GMT 2023
Edited
by admin
on Sat Dec 16 19:19:53 GMT 2023
Record UNII
VQ47T8DE6U
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
MFZ10-7 hydrobromide
Common Name English
Benzonitrile, 3-fluoro-5-[2-(6-methyl-2-pyridinyl)ethynyl]-, hydrobromide (1:1)
Systematic Name English
MFZ-10-7 hydrobromide
Common Name English
Code System Code Type Description
FDA UNII
VQ47T8DE6U
Created by admin on Sat Dec 16 19:19:53 GMT 2023 , Edited by admin on Sat Dec 16 19:19:53 GMT 2023
PRIMARY
CAS
1380072-52-5
Created by admin on Sat Dec 16 19:19:53 GMT 2023 , Edited by admin on Sat Dec 16 19:19:53 GMT 2023
PRIMARY
PUBCHEM
166177251
Created by admin on Sat Dec 16 19:19:53 GMT 2023 , Edited by admin on Sat Dec 16 19:19:53 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE